National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Bill 2021
Became law
| Act | National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 |
|---|---|
| Number | No. 139, 2021 |
| Assent | 13 Dec 2021 |
| Status | In force |
Sourced from the Federal Register of Legislation at 21 Nov 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.
Progress
| Date | Step |
|---|---|
| House | |
| 28 Oct 2021 | Introduced and read a first time |
| 28 Oct 2021 | Second reading moved |
| 29 Nov 2021 | Second reading debate |
| 30 Nov 2021 | Second reading debate |
| 30 Nov 2021 | Second reading agreed to |
| 30 Nov 2021 | Consideration in detail debate |
| 30 Nov 2021 | Third reading agreed to |
| Senate | |
| 30 Nov 2021 | Introduced and read a first time |
| 30 Nov 2021 | Second reading moved |
| 2 Dec 2021 | Second reading debate |
| 2 Dec 2021 | Second reading agreed to |
| 2 Dec 2021 | Committee of the Whole debate |
| 2 Dec 2021 | Third reading agreed to |
| 2 Dec 2021 | Finally passed both Houses |
| 13 Dec 2021 | Assent |
Amends the: National Health Act 1953 to:
- provide for price reductions on the fifth, tenth and fifteenth anniversary of a drug listing on the Pharmaceutical Benefits Scheme (PBS), and when the first new brand of a drug lists on the PBS
- retain ministerial discretion to ensure that the minister can intervene if a legislated price reduction were to have an unintended consequence
- establish a price reduction floor, and stockholding requirements, for certain PBS listed brands that may be susceptible to global medicines shortages
- National Health Amendment (Pharmaceutical Benefits—Budget and Other Measures) Act 2018 to remove redundant provisions.
Summary from the official bill homepage.
Documents
Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.